loadpatents
name:-0.023934125900269
name:-0.015732049942017
name:-0.0061957836151123
Kulkarni; Amol Patent Filings

Kulkarni; Amol

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kulkarni; Amol.The latest application filed is for "analysis of malware".

Company Profile
5.19.24
  • Kulkarni; Amol - Washington DC
  • Kulkarni; Amol - Silver Spring MD
  • Kulkarni; Amol - Bothell WA
  • Kulkarni; Amol - Hillsboro OR
  • KULKARNI; Amol - BARODA IN
  • KULKARNI; Amol - Aurangabad IN
  • KULKARNI; Amol - Parbhani - 1 MAHARASHTRA
  • Kulkarni; Amol - Goa N/A IN
  • Kulkarni; Amol - Beaverton OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia
Grant 11,319,273 - Nwulia , et al. May 3, 2
2022-05-03
NADPH oxidase inhibitors and uses thereof
Grant 11,236,053 - Guner , et al. February 1, 2
2022-02-01
Analysis of Malware
App 20210117544 - Kurtz; George Robert ;   et al.
2021-04-22
Fast and secure protocol to bootstrap a blockchain by restoring the blockchain state using trusted execution environment
Grant 10,936,723 - Gopalakrishnan , et al. March 2, 2
2021-03-02
NADPH Oxidase Inhibitors and Uses Thereof
App 20200270214 - Guner; Osman ;   et al.
2020-08-27
Pharmaceutical Composition Of Nilotinib
App 20200163962 - JAHAGIRDAR; Harshal ;   et al.
2020-05-28
Sandboxing for multi-tenancy
Grant 10,467,058 - Venkataramanappa , et al. No
2019-11-05
Fast And Secure Protocol To Bootstrap A Blockchain By Restoring The Blockchain State Using Trusted Execution Environment
App 20190220603 - Gopalakrishnan; Manoj ;   et al.
2019-07-18
Oral pharmaceutical dosage forms of budesonide
Grant 10,172,802 - Thennati , et al. J
2019-01-08
Pharmaceutical Compositions Of Dimethyl Fumarate
App 20180369183 - THENNATI; Rajamannar ;   et al.
2018-12-27
Pharmaceutical compositions of dimethyl fumarate
Grant 10,085,961 - Thennati , et al. October 2, 2
2018-10-02
Antibacterial Compositions
App 20180256592 - PATEL; Mahesh Vithalbhai ;   et al.
2018-09-13
Oral Pharmaceutical Dosage Forms Of Budesonide
App 20170281556 - Thennati; Rajamannar ;   et al.
2017-10-05
Method Of Administering Divalproex
App 20170273923 - Suhagiya; Vishal ;   et al.
2017-09-28
Antibacterial Compositions
App 20170252351 - PATEL; Mahesh Vithalbhai ;   et al.
2017-09-07
Oral pharmaceutical dosage forms of budesonide
Grant 9,707,182 - Thennati , et al. July 18, 2
2017-07-18
Oral Pharmaceutical Dosage Forms Of Budesonide
App 20170071863 - Thennati; Rajamannar ;   et al.
2017-03-16
Pharmaceutical Compositions Of Dimethyl Fumarate
App 20160346393 - THENNATI; Rajamannar ;   et al.
2016-12-01
Lipophilic Curcumin Analogs And Methods Of Inhibiting HIV-1, Treating Latent HIV In The Brain, And Preventing HIV-Mediated Cognitive Decline And HIV Dementia
App 20160009623 - Nwulia; Evaristus A. ;   et al.
2016-01-14
Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
Grant 9,173,848 - Khullar , et al. November 3, 2
2015-11-03
Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia
Grant 9,012,490 - Nwulia , et al. April 21, 2
2015-04-21
Method and apparatus for secured embedded device communication
Grant 8,949,598 - Chhabra , et al. February 3, 2
2015-02-03
Lipophilic Curcumin Analogs And Methods Of Inhibiting HIV-1, Treating Latent HIV In The Brain, And Preventing HIV-Mediated Cognitive Decline And HIV Dementia
App 20140051742 - Nwulia; Evaristus A. ;   et al.
2014-02-20
Sandboxing For Multi-tenancy
App 20130160115 - Venkataramanappa; Girish Mittur ;   et al.
2013-06-20
Multi-tenant, high-density container service for hosting stateful and stateless middleware components
Grant 8,468,548 - Kulkarni , et al. June 18, 2
2013-06-18
Solid Pharmaceutical Formulations Of Ramipril And Amlodipine Besylate, And Their Preparation
App 20130146496 - Khullar; Praveen ;   et al.
2013-06-13
Method and Apparatus for Secured Embedded Device Communication
App 20120272057 - CHHABRA; Jasmeet ;   et al.
2012-10-25
Multi-tenant, High-density Container Service For Hosting Stateful And Stateless Middleware Components
App 20120159523 - Kulkarni; Amol ;   et al.
2012-06-21
Method and apparatus for secured embedded device communication
Grant 8,091,123 - Chhabra , et al. January 3, 2
2012-01-03
Method for secure device discovery and introduction
Grant 8,001,584 - Lortz , et al. August 16, 2
2011-08-16
Apparatus and method for configuring data plane behavior on network forwarding elements
Grant 7,646,759 - Hegde , et al. January 12, 2
2010-01-12
Method And Apparatus For Secured Embedded Device Communication
App 20090249463 - Chhabra; Jasmeet ;   et al.
2009-10-01
Automatic secure device introduction and configuration
App 20070079113 - Kulkarni; Amol ;   et al.
2007-04-05
Method for secure device discovery and introduction
App 20070079362 - Lortz; Victor B. ;   et al.
2007-04-05
Apparatus and method for configuring data plane behavior on network forwarding elements
App 20040131079 - Hegde, Shriharsha S. ;   et al.
2004-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed